• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Evolv Technology Reports Record Second Quarter Financial Results

    8/10/23 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology
    Get the next $EVLV alert in real time by email

    – Company Raises Outlook for 2023 –

    • Q2 Revenue of $19.8 million, up 119% year-over-year
    • Q2 Ending ARR1 of $54.3 million, up 160% year-over-year
    • Q2 Ending RPO2 of $198.3 million, up 145% year-over-year
    • Q2 Ending Evolv Express® subscriptions of 3,386, up 195% year-over-year

    Evolv Technology (NASDAQ:EVLV), the leader in AI-based weapons detection security screening, today announced financial results for the quarter ended June 30, 2023 and raised its business outlook for 2023.

    Results for the Second Quarter of 2023

    Total revenue for the second quarter of 2023 was $19.8 million, an increase of 119% compared to $9.1 million for the second quarter of 2022. Annual Recurring Revenue ("ARR")1 was $54.3 million at the end of second quarter of 2023, an increase of 160% compared to $20.9 million at the end of the second quarter of 2022. Net loss for the second quarter of 2023 was $(66.8) million, or $(0.45) per basic and diluted share, compared to net loss of $(25.7) million, or $(0.18) per basic and diluted share, in the second quarter of 2022. Adjusted earnings (loss)3 for the second quarter of 2023 was $(14.3) million, or $(0.10) per diluted share, compared to adjusted earnings (loss)3 of $(17.3) million, or $(0.12) per diluted share, for the second quarter of 2022. Adjusted EBITDA3 for the second quarter of 2023 was $(13.8) million compared to $(16.4) million in the second quarter of 2022. As of June 30, 2023, the Company had cash, cash equivalents, and restricted cash of $156.8 million and no debt.

    Results for the First Six Month of 2023

    Total revenue for the six months ended June 30, 2023 was $38.4 million, an increase of 116% compared to $17.8 million for the six months ended June 30, 2022. Net loss for the six months ended June 30, 2023 was $(95.4) million, or $(0.65) per basic and diluted share, compared to net loss of $(39.5) million, or $(0.28) per basic and diluted share, in the six months ended June 30, 2022. Adjusted earnings (loss)3 for the six months ended June 30, 2023 was $(31.2) million, or $(0.21) per diluted share, compared to adjusted earnings (loss)3 of $(35.8) million, or $(0.25) per diluted share, for the six months ended June 30, 2022. Adjusted EBITDA3 for the six months ended June 30, 2023 was $(29.3) million compared to $(33.7) million in the six months ended June 30, 2022.

    The following table summarizes the breakdown of recurring and non-recurring revenue4 during each quarter:

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

    2022

     

    % Change

     

     

    2023

     

     

    2022

     

    % Change

    Recurring revenue

    $

    11,689

     

    $

    4,604

     

    154

    %

     

    $

    20,764

     

    $

    7,763

     

    167

    %

    Non-recurring revenue

     

    8,136

     

     

    4,466

     

    82

    %

     

     

    17,642

     

     

    10,017

     

    76

    %

    Total revenue

    $

    19,825

     

    $

    9,070

     

    119

    %

     

    $

    38,406

     

    $

    17,780

     

    116

    %

    The following table summarizes operating cash flows during each quarter:

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Net loss

    $

    (66,754

    )

     

    $

    (25,686

    )

     

    $

    (95,363

    )

     

    $

    (39,487

    )

    Non-cash (income) expense

     

    54,467

     

     

     

    7,758

     

     

     

    68,472

     

     

     

    2,632

     

    Changes in operating assets and liabilities

     

    7,208

     

     

     

    (5,137

    )

     

     

    18,378

     

     

     

    (15,640

    )

    Net cash used in operating activities

    $

    (5,079

    )

     

    $

    (23,065

    )

     

    $

    (8,513

    )

     

    $

    (52,495

    )

    Company Raises Outlook for 2023

    The Company today commented on its business outlook for 2023. The Company's outlook is based on the current indications for its business, which may change at any time.

     

     

    2023 Business Outlook

    Estimate (In millions)

     

    Issued May 10, 2023

     

    Issued August 10, 2023

    Total Revenue

     

    $60-$65

     

    $70-$75

    Annual Recurring Revenue1 (ARR) at 12/31/23

     

    $67-$71

     

    $70-$72

    Adjusted Gross Margin3

     

    35%-40%

     

    38%-42%

    Adjusted EBITDA3

     

    ($53-$58)

     

    ($52-$56)

    Company to Host Live Conference Call and Webcast

    The Company's management team plans to host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss the financial results as well as management's outlook for the business and other matters. The conference call may be accessed in the United States by dialing +1.877.692.8955 and using access code 825879. The conference call may be accessed outside of the United States by dialing +1.234.720.6979 and using the same access code. The conference call will be simultaneously webcast on the Company's investor relations website, which can be accessed at http://ir.evolvtechnology.com. A replay of the conference call will be available for a period of 30 days by dialing +1.866.207.1041 or +1.402.970.0847 and using access code 1955791 or by accessing the webcast replay on the Company's investor relations website at http://ir.evolvtechnology.com.

    About Evolv Technology

    Evolv Technology (NASDAQ:EVLV) is transforming human security to make a safer, faster, and better experience for the world's most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered weapons detection and analytics. Its mission is to transform security to create a safer world to work, learn, and play. Evolv has digitally transformed the gateways in places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv's advanced systems have scanned more than 750 million people, second only to the Department of Homeland Security's Transportation Security Administration (TSA) in the United States. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category. Evolv Technology®, Evolv Express®, Evolv Insights®, and Evolv Cortex AI® are registered trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit https://evolvtechnology.com.

    1 We define Annual Recurring Revenue, or ARR, as subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter normalized to a one-year period. Our calculation of ARR is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases) that may cause any such contract not to be renewed on its existing terms. In addition, the amount of actual revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly. This may occur due to new bookings, cancellations, upgrades, downgrades or other changes in pending renewals, as well as the effects of professional services revenue and acquisitions or divestitures. As a result, ARR should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

    2 We define Remaining Performance Obligation, or RPO, as estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied or partially satisfied as of the end of the quarter.

    3 Non-GAAP Financial Measures In this press release, the Company's adjusted gross profit (loss), adjusted gross margin, adjusted operating expenses, adjusted operating income (loss), adjusted EBITDA, adjusted earnings (loss), and adjusted earnings per diluted share are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted gross profit and adjusted gross margin exclude one-time items and stock-based compensation expense which management believes provides a more meaningful representation of contribution margin. Adjusted operating expenses is defined as operating expenses less one-time items, stock-based compensation expense, restructuring expenses, and loss on impairment of lease equipment which management believes provides a more meaningful representation of on-going operating expense levels. Adjusted EBITDA is defined as net income (loss) plus depreciation and amortization, share-based compensation, and certain other one-time expenses. Adjusted earnings (loss) is defined as net income (loss) plus stock-based compensation, change in fair value of derivative liability, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, change in fair value of common stock warrant liability, restructuring expenses, loss on impairment of lease equipment, and certain other one-time expenses. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operating performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures included in this press release. The Company is unable to provide a reconciliation of Adjusted Gross Margin to GAAP Gross Margin and non-GAAP Adjusted EBITDA to Net Income (Loss), each measure's most directly comparable GAAP financial measure, on a forward-looking basis without unreasonable effort, because items that impact these GAAP financial measures are not within the Company's control and/or cannot be reasonably predicted. These items may include, but are not limited to, predicting forward-looking share-based compensation, changes in the fair value of derivative liabilities, changes in the fair value of contingent earn out liabilities, changes in the fair value of contingently issuable common stock liabilities and changes in fair value of public warrant liabilities. Such information may have a significant, and potentially unpredictable, impact on the Company's future financial results.

    4 Recurring revenue includes the recurring portion of revenue associated with pure subscription contracts and hardware purchase subscription contracts. Non-recurring revenue includes revenue that is one-time in nature, such as product revenue, shipping revenue, and revenue from installation, training, and professional services.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release other than statements of historical facts, including without limitation statements regarding our ability to meet our 2023 annual guidance for revenue, ARR, adjusted gross margin, and adjusted EBITDA, as well as our estimates for cash and cash equivalents for fiscal year 2023. Words such as "believe" "may," "will," "expect," "should," "could," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "project," "plan," "target," "is/are likely to" or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: expectations regarding the Company's strategies and future financial performance, including its future business plans or objectives, prospective performance, competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, and capital expenditures; the Company's history of losses and lack of profitability; the Company's reliance on third party contract manufacturing and a global supply chain; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the loss of designation of the Evolv Express system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act; the ability for the Company to obtain, maintain, protect and enforce the Company's intellectual property rights and use of "open source" software; the concentration of the Company's revenues on a single solution; the Company's ability to timely design, produce and launch its solutions, the Company's ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company's securities; risks related to existing and changing tax laws; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; the impact of fluctuating general economic and market conditions; the need for additional capital to support business growth, which might not be available on acceptable terms, if at all; litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources, and the Company's ability to identify and implement digital advances in its technology. These and other important factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Securities and Exchange Commission ("SEC") on March 24, 2023, as may be updated from time to time in other filings we make with the SEC including our Quarterly Report on Form 10-Q for the quarter ended on March 31, 2023 that was filed with the SEC on May 10, 2023, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release.

    These statements reflect management's current expectations regarding future events and operating performance and speak only as of the date of this press release. You should not put undue reliance on any forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

     

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Revenue:

     

     

     

     

     

     

     

    Product revenue

    $

    7,243

     

     

    $

    4,146

     

     

    $

    15,997

     

     

    $

    9,340

     

    Subscription revenue

     

    7,964

     

     

     

    4,006

     

     

     

    14,430

     

     

     

    7,010

     

    Service revenue

     

    4,618

     

     

     

    918

     

     

     

    7,979

     

     

     

    1,430

     

    Total revenue

     

    19,825

     

     

     

    9,070

     

     

     

    38,406

     

     

     

    17,780

     

    Cost of revenue:

     

     

     

     

     

     

     

    Cost of product revenue

     

    7,722

     

     

     

    5,347

     

     

     

    18,300

     

     

     

    10,553

     

    Cost of subscription revenue

     

    3,406

     

     

     

    1,981

     

     

     

    5,757

     

     

     

    3,523

     

    Cost of service revenue

     

    1,284

     

     

     

    1,189

     

     

     

    2,171

     

     

     

    2,254

     

    Total cost of revenue

     

    12,412

     

     

     

    8,517

     

     

     

    26,228

     

     

     

    16,330

     

    Gross profit

     

    7,413

     

     

     

    553

     

     

     

    12,178

     

     

     

    1,450

     

    Operating expenses:

     

     

     

     

     

     

     

    Research and development

     

    6,395

     

     

     

    4,156

     

     

     

    11,784

     

     

     

    8,331

     

    Sales and marketing

     

    13,613

     

     

     

    11,751

     

     

     

    26,417

     

     

     

    21,423

     

    General and administrative

     

    10,874

     

     

     

    9,612

     

     

     

    19,800

     

     

     

    20,429

     

    Loss from impairment of property and equipment

     

    157

     

     

     

    316

     

     

     

    294

     

     

     

    412

     

    Total operating expenses

     

    31,039

     

     

     

    25,835

     

     

     

    58,295

     

     

     

    50,595

     

    Loss from operations

     

    (23,626

    )

     

     

    (25,282

    )

     

     

    (46,117

    )

     

     

    (49,145

    )

    Other income (expense), net:

     

     

     

     

     

     

     

    Interest expense

     

    —

     

     

     

    (159

    )

     

     

    (654

    )

     

     

    (301

    )

    Interest income

     

    1,853

     

     

     

    491

     

     

     

    2,806

     

     

     

    559

     

    Other expense, net

     

    (22

    )

     

     

    —

     

     

     

    (3

    )

     

     

    —

     

    Loss on extinguishment of debt

     

    —

     

     

     

    —

     

     

     

    (626

    )

     

     

    —

     

    Change in fair value of contingent earn-out liability

     

    (28,113

    )

     

     

    (569

    )

     

     

    (31,431

    )

     

     

    2,509

     

    Change in fair value of contingently issuable common stock liability

     

    (5,095

    )

     

     

    (24

    )

     

     

    (5,837

    )

     

     

    1,448

     

    Change in fair value of public warrant liability

     

    (11,751

    )

     

     

    (143

    )

     

     

    (13,501

    )

     

     

    5,443

     

    Total other income (expense), net

     

    (43,128

    )

     

     

    (404

    )

     

    $

    (49,246

    )

     

    $

    9,658

     

    Net loss

    $

    (66,754

    )

     

    $

    (25,686

    )

     

    $

    (95,363

    )

     

    $

    (39,487

    )

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding – basic and diluted

     

    148,882,160

     

     

     

    143,552,032

     

     

     

    147,664,534

     

     

     

    143,220,268

     

    Net loss per share - basic and diluted

    $

    (0.45

    )

     

    $

    (0.18

    )

     

    $

    (0.65

    )

     

    $

    (0.28

    )

     

     

     

     

     

     

     

     

    Net loss

    $

    (66,754

    )

     

    $

    (25,686

    )

     

    $

    (95,363

    )

     

    $

    (39,487

    )

    Other comprehensive income (loss)

     

     

     

     

     

     

     

    Cumulative translation adjustment

     

    (17

    )

     

     

    (10

    )

     

     

    (33

    )

     

     

    (10

    )

    Total other comprehensive loss

     

    (17

    )

     

     

    (10

    )

     

     

    (33

    )

     

     

    (10

    )

    Total comprehensive loss

    $

    (66,771

    )

     

    $

    (25,696

    )

     

    $

    (95,396

    )

     

    $

    (39,497

    )

     

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    June 30, 2023

     

    December 31, 2022

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    155,537

     

     

    $

    229,783

     

    Restricted cash

     

    1,000

     

     

     

    —

     

    Accounts receivable, net

     

    32,393

     

     

     

    31,920

     

    Inventory

     

    5,032

     

     

     

    10,257

     

    Current portion of contract assets

     

    4,732

     

     

     

    2,852

     

    Current portion of commission asset

     

    3,648

     

     

     

    3,384

     

    Prepaid expenses and other current assets

     

    13,808

     

     

     

    14,388

     

    Total current assets

     

    216,150

     

     

     

    292,584

     

    Restricted cash, noncurrent

     

    275

     

     

     

    275

     

    Contract assets, noncurrent

     

    690

     

     

     

    1,386

     

    Commission asset, noncurrent

     

    6,649

     

     

     

    5,655

     

    Property and equipment, net

     

    81,085

     

     

     

    44,707

     

    Operating lease right-of-use assets

     

    1,241

     

     

     

    1,673

     

    Other assets

     

    1,878

     

     

     

    1,835

     

    Total assets

    $

    307,968

     

     

    $

    348,115

     

     

     

     

     

    Liabilities and Stockholders' Equity

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    16,912

     

     

    $

    18,194

     

    Accrued expenses and other current liabilities

     

    10,821

     

     

     

    11,545

     

    Current portion of deferred revenue

     

    39,366

     

     

     

    18,273

     

    Current portion of long-term debt

     

    —

     

     

     

    10,000

     

    Current portion of operating lease liabilities

     

    1,130

     

     

     

    1,114

     

    Total current liabilities

     

    68,229

     

     

     

    59,126

     

    Deferred revenue, noncurrent

     

    20,715

     

     

     

    17,695

     

    Long-term debt, noncurrent

     

    —

     

     

     

    19,683

     

    Operating lease liabilities, noncurrent

     

    363

     

     

     

    892

     

    Contingent earn-out liability

     

    45,649

     

     

     

    14,218

     

    Contingently issuable common stock liability

     

    9,229

     

     

     

    3,392

     

    Public warrant liability

     

    19,625

     

     

     

    6,124

     

    Total liabilities

     

    163,810

     

     

     

    121,130

     

     

     

     

     

    Stockholders' equity:

     

     

     

    Preferred stock, $0.0001 par value; 100,000,000 authorized at June 30, 2023 and December 31, 2022; no shares issued and outstanding at June 30, 2023 and December 31, 2022

     

    —

     

     

     

    —

     

    Common stock, $0.0001 par value; 1,100,000,000 shares authorized at June 30, 2023 and December 31, 2022; 149,790,742 and 145,204,974 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively

     

    15

     

     

     

    15

     

    Additional paid-in capital

     

    431,759

     

     

     

    419,190

     

    Accumulated other comprehensive loss

     

    (43

    )

     

     

    (10

    )

    Accumulated deficit

     

    (287,573

    )

     

     

    (192,210

    )

    Stockholders' equity

     

    144,158

     

     

     

    226,985

     

    Total liabilities and stockholders' equity

    $

    307,968

     

     

    $

    348,115

     

     

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited)

     

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

     

    2022

     

    Cash flows from operating activities:

     

     

     

    Net loss

    $

    (95,363

    )

     

    $

    (39,487

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

    Depreciation and amortization

     

    4,087

     

     

     

    2,350

     

    Write-off of inventory and change in inventory reserve

     

    337

     

     

     

    425

     

    Adjustment to property and equipment for sales type leases

     

    —

     

     

     

    (625

    )

    Loss from impairment of property and equipment

     

    294

     

     

     

    412

     

    Stock-based compensation

     

    11,732

     

     

     

    8,988

     

    Non-cash interest expense

     

    22

     

     

     

    10

     

    Non-cash lease expense

     

    432

     

     

     

    392

     

    Change in allowance for expected credit losses

     

    173

     

     

     

    80

     

    Loss on extinguishment of debt

     

    626

     

     

     

    —

     

    Change in fair value of earn-out liability

     

    31,431

     

     

     

    (2,509

    )

    Change in fair value of contingently issuable common stock

     

    5,837

     

     

     

    (1,448

    )

    Change in fair value of public warrant liability

     

    13,501

     

     

     

    (5,443

    )

    Changes in operating assets and liabilities

     

     

     

    Accounts receivable

     

    (646

    )

     

     

    (5,786

    )

    Inventory

     

    5,080

     

     

     

    (3,545

    )

    Commission assets

     

    (1,258

    )

     

     

    (339

    )

    Contract assets

     

    (1,184

    )

     

     

    (1,352

    )

    Other assets

     

    (43

    )

     

     

    (756

    )

    Prepaid expenses and other current assets

     

    580

     

     

     

    (9,707

    )

    Accounts payable

     

    (7,409

    )

     

     

    2,147

     

    Deferred revenue

     

    24,113

     

     

     

    6,031

     

    Accrued expenses and other current liabilities

     

    (342

    )

     

     

    (1,876

    )

    Operating lease liability

     

    (513

    )

     

     

    (457

    )

    Net cash used in operating activities

     

    (8,513

    )

     

     

    (52,495

    )

    Cash flows from investing activities:

     

     

     

    Development of internal-use software

     

    (1,599

    )

     

     

    (1,301

    )

    Purchases of property and equipment

     

    (33,173

    )

     

     

    (11,379

    )

    Proceeds from sale of property and equipment

     

    60

     

     

     

    —

     

    Net cash used in investing activities

     

    (34,712

    )

     

     

    (12,680

    )

    Cash flows from financing activities:

     

     

     

    Proceeds from exercise of stock options and warrants

     

    344

     

     

     

    384

     

    Proceeds from long-term debt

     

    1,876

     

     

     

    —

     

    Repayment of principal on long-term debt

     

    (31,876

    )

     

     

    —

     

    Payment of debt issuance costs and prepayment penalty

     

    (332

    )

     

     

    —

     

    Net cash provided by (used in) financing activities

     

    (29,988

    )

     

     

    384

     

    Effect of exchange rate changes on cash and cash equivalents

     

    (33

    )

     

     

    (10

    )

    Net increase (decrease) in cash, cash equivalents and restricted cash

     

    (73,246

    )

     

     

    (64,801

    )

    Cash, cash equivalents and restricted cash

     

     

     

    Cash, cash equivalents and restricted cash at beginning of period

     

    230,058

     

     

     

    308,167

     

    Cash, cash equivalents and restricted cash at end of period

    $

    156,812

     

     

    $

    243,366

     

     

    EVOLV TECHNOLOGY

    SUMMARY OF KEY OPERATING STATISTICS

    (Unaudited)

     

     

    Three Months Ended or as of,

    ($ in thousands)

     

    March 31,

    2022

     

    June 30,

    2022

     

    September 30,

    2022

     

    December 31,

    2022

     

    March 31,

    2023

     

    June 30,

    2023

    New customers

     

     

    44

     

     

    53

     

     

    92

     

     

    106

     

     

    61

     

     

    74

    Annual recurring revenue

     

    $

    16,641

     

    $

    20,865

     

    $

    28,741

     

    $

    34,120

     

    $

    42,021

     

    $

    54,339

    Recurring revenue

     

    $

    3,159

     

    $

    4,604

     

    $

    6,221

     

    $

    7,388

     

    $

    9,075

     

    $

    11,689

    Remaining performance obligation

     

    $

    63,750

     

    $

    80,978

     

    $

    109,407

     

    $

    144,561

     

    $

    161,813

     

    $

    198,296

    Net additions

     

     

    207

     

     

    237

     

     

    545

     

     

    575

     

     

    520

     

     

    599

    Ending deployed units

     

     

    910

     

     

    1,147

     

     

    1,692

     

     

    2,267

     

     

    2,787

     

     

    3,386

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended,

     

     

     

    March 31,

    2022

     

    June 30,

    2022

     

    September 30,

    2022

     

    December 31,

    2022

     

    March 31,

    2023

     

    June 30,

    2023

    Operating expenses, GAAP

     

    $

    24,760

     

     

    $

    25,835

     

     

    $

    26,827

     

     

    $

    26,868

     

     

    $

    27,256

     

     

    $

    31,039

     

    Stock-based compensation

     

     

    (3,819

    )

     

     

    (4,781

    )

     

     

    (6,298

    )

     

     

    (6,771

    )

     

     

    (4,898

    )

     

     

    (6,505

    )

    Restructuring expenses

     

     

    (324

    )

     

     

    13

     

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    —

     

    Loss on impairment of lease equipment

     

     

    (96

    )

     

     

    (316

    )

     

     

    (626

    )

     

     

    (123

    )

     

     

    (137

    )

     

     

    (157

    )

    Other one-time expenses

     

     

    (1,107

    )

     

     

    (2,298

    )

     

     

    (69

    )

     

     

    (41

    )

     

     

    (53

    )

     

     

    (683

    )

    Adjusted Operating Expenses

     

    $

    19,414

     

     

    $

    18,453

     

     

    $

    19,834

     

     

    $

    19,933

     

     

    $

    22,168

     

     

    $

    23,694

     

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP GROSS PROFIT TO ADJUSTED GROSS PROFIT, GAAP GROSS MARGIN TO ADJUSTED GROSS MARGIN AND GAAP OPERATING INCOME (LOSS) TO ADJUSTED OPERATING INCOME (LOSS)

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Revenue

    $

    19,825

     

     

    $

    9,070

     

     

    $

    38,406

     

     

    $

    17,780

     

    Cost of Revenue

     

    12,412

     

     

     

    8,517

     

     

     

    26,228

     

     

     

    16,330

     

    Gross Profit, GAAP

     

    7,413

     

     

     

    553

     

     

     

    12,178

     

     

     

    1,450

     

    Stock-based compensation

     

    184

     

     

     

    280

     

     

     

    329

     

     

     

    388

     

    Amortization of capitalized stock-based compensation

     

    11

     

     

     

    6

     

     

     

    21

     

     

     

    9

     

    Adjusted Gross Profit

    $

    7,608

     

     

    $

    839

     

     

    $

    12,528

     

     

    $

    1,847

     

     

     

     

     

     

     

     

     

    Gross Margin %

     

    37.4

    %

     

     

    6.1

    %

     

     

    31.7

    %

     

     

    8.2

    %

    Adjusted Gross Margin %

     

    38.4

    %

     

     

    9.3

    %

     

     

    32.6

    %

     

     

    10.4

    %

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Operating income (loss), GAAP

    $

    (23,626

    )

     

    $

    (25,282

    )

     

    $

    (46,117

    )

     

    $

    (49,145

    )

    Stock-based compensation

     

    6,689

     

     

     

    5,061

     

     

     

    11,732

     

     

     

    8,988

     

    Amortization of capitalized stock-based compensation

     

    11

     

     

     

    6

     

     

     

    21

     

     

     

    9

     

    Restructuring expenses

     

    —

     

     

     

    (13

    )

     

     

    —

     

     

     

    311

     

    Loss on impairment of lease equipment

     

    157

     

     

     

    316

     

     

     

    294

     

     

     

    412

     

    Other one-time expenses

     

    683

     

     

     

    2,298

     

     

     

    736

     

     

     

    3,405

     

    Adjusted Operating Income (Loss)

    $

    (16,086

    )

     

    $

    (17,614

    )

     

    $

    (33,334

    )

     

    $

    (36,020

    )

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Net loss

    $

    (66,754

    )

     

    $

    (25,686

    )

     

    $

    (95,363

    )

     

    $

    (39,487

    )

    Depreciation & amortization

     

    2,272

     

     

     

    1,264

     

     

     

    4,087

     

     

     

    2,350

     

    Stock-based compensation

     

    6,689

     

     

     

    5,061

     

     

     

    11,732

     

     

     

    8,988

     

    Interest expense (income)

     

    (1,853

    )

     

     

    (332

    )

     

     

    (2,152

    )

     

     

    (258

    )

    Loss on extinguishment of debt

     

    —

     

     

     

    —

     

     

     

    626

     

     

     

    —

     

    Change in fair value of contingent earn-out liability

     

    28,113

     

     

     

    569

     

     

     

    31,431

     

     

     

    (2,509

    )

    Change in fair value of contingently issuable common stock liability

     

    5,095

     

     

     

    24

     

     

     

    5,837

     

     

     

    (1,448

    )

    Change in fair value of public warrant liability

     

    11,751

     

     

     

    143

     

     

     

    13,501

     

     

     

    (5,443

    )

    Restructuring expenses

     

    —

     

     

     

    (13

    )

     

     

    —

     

     

     

    311

     

    Loss on impairment of lease equipment

     

    157

     

     

     

    316

     

     

     

    294

     

     

     

    412

     

    Other one-time expenses

     

    683

     

     

     

    2,298

     

     

     

    736

     

     

     

    3,405

     

    Adjusted EBITDA

    $

    (13,847

    )

     

    $

    (16,356

    )

     

    $

    (29,271

    )

     

    $

    (33,679

    )

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EARNINGS (LOSS)

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Net loss

    $

    (66,754

    )

     

    $

    (25,686

    )

     

    $

    (95,363

    )

     

    $

    (39,487

    )

    Stock-based compensation

     

    6,689

     

     

     

    5,061

     

     

     

    11,732

     

     

     

    8,988

     

    Amortization of capitalized stock-based compensation

     

    11

     

     

     

    6

     

     

     

    21

     

     

     

    9

     

    Loss on extinguishment of debt

     

    —

     

     

     

    —

     

     

     

    626

     

     

     

    —

     

    Change in fair value of contingent earn-out liability

     

    28,113

     

     

     

    569

     

     

     

    31,431

     

     

     

    (2,509

    )

    Change in fair value of contingently issuable common stock liability

     

    5,095

     

     

     

    24

     

     

     

    5,837

     

     

     

    (1,448

    )

    Change in fair value of public warrant liability

     

    11,751

     

     

     

    143

     

     

     

    13,501

     

     

     

    (5,443

    )

    Restructuring expenses

     

    —

     

     

     

    (13

    )

     

     

    —

     

     

     

    311

     

    Loss on impairment of lease equipment

     

    157

     

     

     

    316

     

     

     

    294

     

     

     

    412

     

    Other one-time expenses

     

    683

     

     

     

    2,298

     

     

     

    736

     

     

     

    3,405

     

    Adjusted Earnings (Loss)

    $

    (14,255

    )

     

    $

    (17,282

    )

     

    $

    (31,185

    )

     

    $

    (35,762

    )

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding – diluted

     

    148,882,160

     

     

     

    143,552,032

     

     

     

    147,664,534

     

     

     

    143,220,268

     

     

     

     

     

     

     

     

     

    Adjusted Earnings (Loss) Per Share – diluted

    $

    (0.10

    )

     

    $

    (0.12

    )

     

    $

    (0.21

    )

     

    $

    (0.25

    )

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230810378529/en/

    Get the next $EVLV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EVLV

    DatePrice TargetRatingAnalyst
    8/15/2025$9.00Hold → Buy
    Lake Street
    8/15/2025$10.00Buy
    TD Cowen
    5/21/2025$7.50Market Perform → Outperform
    Northland Capital
    10/28/2024Outperform → Market Perform
    Northland Capital
    5/20/2024$8.50 → $5.75Buy
    Craig Hallum
    5/10/2024$6.00 → $3.50Buy → Hold
    Lake Street
    11/21/2023$6.00Buy
    Lake Street
    4/28/2023$6.00Buy
    Craig Hallum
    More analyst ratings

    $EVLV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ellenbogen Michael sold $500,619 worth of shares (80,745 units at $6.20) and exercised 80,745 shares at a strike of $0.24 (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    1/20/26 4:20:01 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    President & CEO Kedzierski John converted options into 207,000 shares and sold $522,484 worth of shares (74,322 units at $7.03), increasing direct ownership by 1,658% to 140,678 units (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    1/6/26 4:09:10 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    SEC Form 4 filed by Director Sullivan Mark J.

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    1/6/26 4:08:24 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evolv Technologies Holdings upgraded by Lake Street with a new price target

    Lake Street upgraded Evolv Technologies Holdings from Hold to Buy and set a new price target of $9.00

    8/15/25 8:30:18 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    TD Cowen resumed coverage on Evolv Technologies Holdings with a new price target

    TD Cowen resumed coverage of Evolv Technologies Holdings with a rating of Buy and set a new price target of $10.00

    8/15/25 8:18:59 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technologies Holdings upgraded by Northland Capital with a new price target

    Northland Capital upgraded Evolv Technologies Holdings from Market Perform to Outperform and set a new price target of $7.50

    5/21/25 8:40:06 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FC Cincinnati Kicks Off 2026 with Addition of Evolv Express® Systems to TQL Stadium Entrances

    Evolv also becomes team and venue's "Official Fan Screening Partner" Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced it has completed a venue-wide installation of Evolv Express® at TQL Stadium in Cincinnati, Ohio. The stadium, which opened in 2021 and has a seating capacity of 26,000, is home to Major League Soccer's FC Cincinnati and has also hosted a wide range of international soccer matches, concerts, and other events. Known for its innovative design, TQL Stadium maintains an intimate feel, despite being one of the largest soccer-specific stadiums in North America

    2/5/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology to Present at TD Cowen Aerospace & Defense Conference

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced its scheduled participation in the TD Cowen Aerospace & Defense Conference on Wednesday, February 11, 2026 at 10:45 a.m. Eastern Time. Presenting on behalf of the Company will be Mr. Anil Chitkara, the Company's Co-Founder and Chief Growth Officer. Additional details including a link to the associated webcast will be available at the Company's investor relations website at https://ir.evolvtechnology.com. About Evolv Technology Evolv (NASDAQ:EVLV) is designed to transform human security by helping organizations det

    2/4/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    East Baton Rouge Parish Schools Triples its Evolv Express Gen2 Fleet, Strengthening Districtwide Security

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, announced today that Louisiana's East Baton Rouge Parish Schools is expanding its partnership with the company. The district, which initially deployed Evolv Express® weapons detection system last year, has added systems to eight more schools in the region. This expansion, in partnership with Alliance Technology Group, reflects the district's ongoing commitment to providing a secure and welcoming environment for its community. With this latest deployment, a total of twelve high schools are now operating Evolv's advanced security technolo

    2/3/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    SEC Filings

    View All

    SEC Form 10-Q filed by Evolv Technologies Holdings Inc.

    10-Q - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

    11/13/25 4:17:45 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technologies Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

    11/13/25 4:07:16 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Evolv Technologies Holdings Inc.

    SCHEDULE 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    10/30/25 3:19:25 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Revenue Officer Marshall Robert E bought $42,420 worth of shares (7,000 units at $6.06) (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    11/25/25 4:03:38 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Director Charlton Kevin M. bought $85,196 worth of shares (15,000 units at $5.68) (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    11/21/25 4:39:17 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Director Shapiro Richard A bought $278,126 worth of shares (46,300 units at $6.01), increasing direct ownership by 133% to 52,515 units (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    11/20/25 4:20:48 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Leadership Updates

    Live Leadership Updates

    View All

    TransAct Appoints Dana Loof as Chief Marketing Officer to Accelerate Growth and Platform Expansion

    TransAct Technologies Incorporated (NASDAQ:TACT) ("TransAct" or the "Company"), a global leader in software-driven technology and integrated printing solutions, today announced the appointment of Dana Loof as Chief Marketing Officer. Ms. Loof will lead TransAct's global marketing organization, with a mandate to strengthen brand leadership, sharpen go-to-market execution, and accelerate adoption of the Company's growing technology portfolio. Ms. Loof has a 30-year track record leading high-growth technology companies, where she has been responsible for global marketing strategy, brand strategy and positioning, category building, revenue generation, and customer engagement initiatives. In h

    1/20/26 4:05:00 PM ET
    $EVLV
    $TACT
    Computer peripheral equipment
    Technology

    Evolv Extends Partnership with New England Patriots, New England Revolution, and Gillette Stadium

    Extension of original 2021 agreement includes expansion of Evolv Express subscription, and official partnership designations Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced that it renewed its partnership with Gillette Stadium, home of the New England Patriots and New England Revolution. The renewal, which extends a partnership initiated in 2021, increases the number of entry points at which Evolv Express® security screening will be used. All members of the public entering the stadium for football games, soccer matches, concerts, and other events will pass through an

    9/16/25 12:00:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology Appoints Chris Kutsor as Chief Financial Officer

    –Evolv Welcomes Proven High-Tech Public Company CFO as Company Enters New Stage of Growth– Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced the appointment of Mr. Chris Kutsor as Chief Financial Officer. The appointment will be effective one business day following the filing of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423812661/en/Chris Kutsor, Chief Financial Officer "We are thrilled to welcome Chris to our le

    4/23/25 8:00:00 AM ET
    $EVLV
    $MSI
    Computer peripheral equipment
    Technology
    Radio And Television Broadcasting And Communications Equipment

    $EVLV
    Financials

    Live finance-specific insights

    View All

    Evolv Technology to Release Fourth Quarter Financial Results on March 10, 2026

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that the Company will release financial results for the fourth quarter of 2025 on Tuesday, March 10, 2026, after the market closes. Members of the Company's management team plan to host a live webcast at 4:30 p.m. Eastern Time on that day to discuss the financial results as well as management's outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com. About Evolv Technology Evolv (NASDAQ:EVLV) is designed to transform human security by helping organizations detect potential

    2/2/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology Reports Third Quarter Financial Results

    — Company Raises Revenue Outlook for 2025 to $142-$145 Million, up 37%-40% Year-Over-Year — Q3'25 Revenue of $42.9 million, up 57% year-over-year Q3'25 Ending ARR1 of $117.2 million, up 25% year-over-year Q3'25 Net Loss of $(1.8) million, with Net Profit Margin of (4)% Q3'25 Adjusted EBITDA2 of $5.1 million, with Adjusted EBITDA Margin2 of 12% Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended September 30, 2025. "We made meaningful progress across many key measures of the business in the third quarter—including

    11/13/25 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology to Release Third Quarter Financial Results on November 13, 2025

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that the Company will release financial results for the third quarter of 2025 on Thursday, November 13, 2025, after the market closes. Members of the Company's management team plan to host a live webcast at 4:30 p.m. Eastern Time on that day to discuss the financial results as well as management's outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com. About Evolv Technology Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) is designed to transform human security by helping

    10/6/25 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    12/12/24 3:21:41 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    11/12/24 2:31:40 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    11/7/24 4:31:46 PM ET
    $EVLV
    Computer peripheral equipment
    Technology